Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition from “AI” to “SI” appears above the page, which still displays a 403 error. The footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:47:48.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page; no study details are shown.
    Difference
    0.2%
    Check dated 2026-10-06T21:48:35.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study page now loads a 403 Forbidden error instead of displaying the trial details, indicating the record is currently inaccessible. The error page is shown with the standard site chrome and a 403 message, preventing access to the study information.
    Difference
    20%
    Check dated 2026-09-22T23:09:50.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.6 to v3.7.0, indicating a backend or version update rather than changes to the displayed content.
    Difference
    0.0%
    Check dated 2026-09-15T21:58:58.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating an update to the page version. This update is metadata and does not change the study information presented.
    Difference
    0.0%
    Check dated 2026-09-01T17:52:55.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend or frontend update; no user-facing content changes to the study details are evident from the given changes.
    Difference
    0.0%
    Check dated 2026-08-11T15:33:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.